HRP20031017A2 - Pyrrolidine oxasidiazole- and thiadiazole derivatives - Google Patents

Pyrrolidine oxasidiazole- and thiadiazole derivatives

Info

Publication number
HRP20031017A2
HRP20031017A2 HR20031017A HRP20031017A HRP20031017A2 HR P20031017 A2 HRP20031017 A2 HR P20031017A2 HR 20031017 A HR20031017 A HR 20031017A HR P20031017 A HRP20031017 A HR P20031017A HR P20031017 A2 HRP20031017 A2 HR P20031017A2
Authority
HR
Croatia
Prior art keywords
oxasidiazole
pyrrolidine
thiadiazole derivatives
thiadiazole
derivatives
Prior art date
Application number
HR20031017A
Other languages
English (en)
Inventor
Matthias Schwarz
Patrick Page
Vincent Pomel
Anna Quattropani
Russel J Thomas
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of HRP20031017A2 publication Critical patent/HRP20031017A2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HR20031017A 2001-06-18 2003-12-08 Pyrrolidine oxasidiazole- and thiadiazole derivatives HRP20031017A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01113632 2001-06-18
PCT/EP2002/006629 WO2002102799A2 (en) 2001-06-18 2002-06-14 Pyrrolidine oxadiazole- and thiadiazole oxime derivatives being oxytocin receptor antagonists

Publications (1)

Publication Number Publication Date
HRP20031017A2 true HRP20031017A2 (en) 2004-04-30

Family

ID=8177641

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20031017A HRP20031017A2 (en) 2001-06-18 2003-12-08 Pyrrolidine oxasidiazole- and thiadiazole derivatives

Country Status (27)

Country Link
US (2) US7115639B2 (es)
EP (1) EP1444225B1 (es)
JP (1) JP4426284B2 (es)
KR (1) KR20040030678A (es)
CN (1) CN100564378C (es)
AR (1) AR036108A1 (es)
AU (1) AU2002319237B2 (es)
BG (1) BG108424A (es)
BR (1) BR0211030A (es)
CA (1) CA2449578C (es)
CZ (1) CZ20033475A3 (es)
EA (1) EA006212B1 (es)
EE (1) EE200400022A (es)
ES (1) ES2397305T3 (es)
HK (1) HK1074204A1 (es)
HR (1) HRP20031017A2 (es)
HU (1) HUP0400238A2 (es)
IL (1) IL159219A0 (es)
MX (1) MXPA03011441A (es)
MY (1) MY128890A (es)
NO (1) NO20035399L (es)
PL (1) PL367275A1 (es)
RS (1) RS99503A (es)
SK (1) SK15552003A3 (es)
UA (1) UA75145C2 (es)
WO (1) WO2002102799A2 (es)
ZA (1) ZA200309402B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040030678A (ko) 2001-06-18 2004-04-09 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. 피롤리딘 옥사디아졸 및 티아디아졸 유도체
US7557136B2 (en) * 2003-02-27 2009-07-07 Laboratoires Serono Sa Pyrrolidine derivatives as oxytocin antagonists
EP1725526B1 (en) * 2004-02-26 2007-12-12 Laboratoires Serono SA Method for preparing pyrrolidine oximes
KR101562549B1 (ko) 2005-05-10 2015-10-23 인사이트 홀딩스 코포레이션 인돌아민 2,3-디옥시게나제의 조절제 및 이의 사용방법
TWI382974B (zh) 2005-12-20 2013-01-21 Incyte Corp 作為吲哚胺２，３-二氧化酶調節劑之ｎ-羥基甲脒基雜環化物
US20080125470A1 (en) 2006-09-19 2008-05-29 Incyte Corporation N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
CL2007002650A1 (es) 2006-09-19 2008-02-08 Incyte Corp Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras.
PE20110308A1 (es) 2008-07-08 2011-06-10 Incyte Corp 1,2,5-oxadiazoles como inhibidores de indolamina 2,3-dioxigenasa
EP2845850A1 (en) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
EP3066085B1 (en) 2013-11-08 2020-05-13 Incyte Holdings Corporation Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
CN114105850A (zh) 2014-07-02 2022-03-01 奥布赛瓦股份公司 治疗ot-r活性相关的病症的方法中可用的晶体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722190B1 (fr) 1994-07-05 1996-10-04 Sanofi Sa Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
AU4763896A (en) 1995-01-24 1996-08-14 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
US5756497A (en) 1996-03-01 1998-05-26 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
FR2757157B1 (fr) 1996-12-13 1999-12-31 Sanofi Sa Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant
JP2002543129A (ja) 1999-05-05 2002-12-17 メルク エンド カムパニー インコーポレーテッド 抗微生物剤としての新規なプロリン類
WO2001074769A1 (en) * 2000-03-27 2001-10-11 Applied Research Systems Ars Holding N.V. Pharmaceutically active pyrrolidine derivatives as bax inhibitors
AU2001256209B2 (en) * 2000-03-27 2006-02-16 Merck Serono Sa Pharmaceutically active pyrrolidine derivatives
AU1401902A (en) * 2000-10-17 2002-04-29 Applied Research Systems Pharmaceutically active sulfanilide derivatives
ATE394371T1 (de) * 2001-03-20 2008-05-15 Serono Lab Pyrrolidinesterderivate mit oxytocinmodulierender wirkung
KR20040030678A (ko) 2001-06-18 2004-04-09 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. 피롤리딘 옥사디아졸 및 티아디아졸 유도체
WO2003053437A1 (en) * 2001-12-20 2003-07-03 Applied Research Systems Ars Holding N.V. Triazoles as oxytocin antagonists
UA78058C2 (en) * 2002-07-05 2007-02-15 Applied Research Systems Pyrrolidine derivative as oxitocin antagonists

Also Published As

Publication number Publication date
EP1444225B1 (en) 2012-10-10
EA200400049A1 (ru) 2004-08-26
EE200400022A (et) 2004-04-15
JP4426284B2 (ja) 2010-03-03
NO20035399D0 (no) 2003-12-04
HUP0400238A2 (hu) 2004-07-28
MY128890A (en) 2007-02-28
JP2004534804A (ja) 2004-11-18
KR20040030678A (ko) 2004-04-09
CA2449578A1 (en) 2002-12-27
US7115639B2 (en) 2006-10-03
ZA200309402B (en) 2004-12-03
CA2449578C (en) 2011-12-13
US20060229343A1 (en) 2006-10-12
AR036108A1 (es) 2004-08-11
SK15552003A3 (sk) 2004-05-04
BG108424A (en) 2005-03-31
WO2002102799A2 (en) 2002-12-27
BR0211030A (pt) 2004-06-22
CZ20033475A3 (en) 2004-05-12
WO2002102799A3 (en) 2003-04-03
UA75145C2 (en) 2006-03-15
MXPA03011441A (es) 2004-07-01
NO20035399L (no) 2004-02-17
ES2397305T3 (es) 2013-03-06
EP1444225A2 (en) 2004-08-11
AU2002319237B2 (en) 2008-01-03
RS99503A (en) 2006-12-15
PL367275A1 (en) 2005-02-21
CN1639155A (zh) 2005-07-13
HK1074204A1 (en) 2005-11-04
IL159219A0 (en) 2004-06-01
CN100564378C (zh) 2009-12-02
US20040220238A1 (en) 2004-11-04
EA006212B1 (ru) 2005-10-27

Similar Documents

Publication Publication Date Title
HK1074204A1 (en) Pyrrolidine oxadiazole-and thiadiazole derivatives
EG22695A (en) Novel phenyl-propargylether derivatives
HK1068608A1 (en) 3-Substituted-4-pyrimidone derivatives
ZA200309522B (en) Substituted cyclohexane-1-4diamine derivatives
EP1392664A4 (en) EPOTHILONE DERIVATIVES
HUP0301330A3 (en) 2-aminocarbonyl-9h-purine derivatives
HRP20030055A2 (en) 4-phenyl-pyridine derivatives
IL150841A0 (en) 1h-imidazopyridine derivatives
IL160642A0 (en) Pyrrolidinone derivatives
IL158388A0 (en) Novel arylheteroalkylamine derivatives
GB0106177D0 (en) Piperazine derivatives
HUP0303449A3 (en) Substituted benzofuran-2-carboxamides derivatives
HK1068607A1 (en) Phenylalkyloxy-phenyl derivatives
HUP0303186A3 (en) 4-aminobenzopyran derivatives
HUP0401949A3 (en) 4-imidazolin-2-one derivatives
HUP0500026A3 (en) N-heteroarylnicotinamide derivatives
PL356565A1 (en) Aminosulfonylbiphenyl derivatives
IL150558A0 (en) Aminomethyl-phenyl-cyclohexanone derivatives
AU2408802A (en) Novel carbapenem derivatives
EP1364954A4 (en) Dicarba closo DODECARBORANDERIVATE
EP1408955A4 (en) NEW METALLOTEXAPHYRINE DERIVATIVES
IL151598A0 (en) 2-phenylpyran-4-one derivatives
SI1427709T1 (sl) 3-substituirani-4-pirimidonski derivati
GB0021639D0 (en) Maurotoxin derivatives
HK1054937A1 (en) 1-Methylcarbapenem derivatives

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
OBST Application withdrawn